Richter Gedeon Nyrt (RICHTER):企業の財務・戦略的SWOT分析

◆英語タイトル:Richter Gedeon Nyrt (RICHTER) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C8765
◆発行会社(調査会社):GlobalData
◆発行日:2018年10月
◆ページ数:43
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:ハンガリー
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥13,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥27,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥40,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Richter Gedeon Nyrt (RICHTER) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Richter Gedeon Nyrt (Richter) is a pharmaceutical company that develops, manufactures and commercializes a wide range of drugs including original, generic and licensed products and over-the-counter (OTC) medicines. The company’s product portfolio encompasses medicines to treat gynaecological diseases, cardiovascular diseases, gastrointestinal diseases and central nervous system disorders. Richter’s research activities focus exclusively on the development of original small molecules, recombinant biotechnology and generic product development. It operates sales network in Hungary, Central Eastern Europe and the Commonwealth of Independent States (CIS) countries. The company has a research and development unit in Central Eastern Europe. Richter is headquartered in Budapest, Hungary.

Richter Gedeon Nyrt Key Recent Developments

Oct 09,2018: Gedeon Richter Plc.: Cariprazine Shows Favorable Safety Parameters and Efficacy in Reducing Schizophrenia Negative Symptoms Compared to Aripiprazole
Sep 18,2018: Announcements Richter signed a license and distribution agreement to enhance its fertility portfolio[TDN Alerts : Others]

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Section 1 – About the Company 6
Richter Gedeon Nyrt – Key Facts 6
Richter Gedeon Nyrt – Key Employees 7
Richter Gedeon Nyrt – Key Employee Biographies 8
Richter Gedeon Nyrt – Major Products and Services 9
Richter Gedeon Nyrt – History 11
Richter Gedeon Nyrt – Company Statement 15
Richter Gedeon Nyrt – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Joint Venture 18
Section 2 – Company Analysis 19
Company Overview 19
Richter Gedeon Nyrt – Business Description 20
Business Segment: Others 20
Overview 20
Performance 20
Business Segment: Pharmaceuticals 20
Overview 20
Performance 20
Key Stats 21
Business Segment: Wholesale and Retail 21
Overview 21
Performance 21
Key Stats 21
Geographical Segment: China 21
Performance 21
Geographical Segment: CIS 21
Performance 21
Geographical Segment: Europe 21
Performance 21
Geographical Segment: Hungary 22
Performance 22
Geographical Segment: Latin America 22
Performance 22
Geographical Segment: ROW 22
Performance 22
Geographical Segment: USA 22
Performance 22
R&D Overview 22
Richter Gedeon Nyrt – Corporate Strategy 23
Richter Gedeon Nyrt – SWOT Analysis 24
SWOT Analysis – Overview 24
Richter Gedeon Nyrt – Strengths 24
Richter Gedeon Nyrt – Weaknesses 25
Richter Gedeon Nyrt – Opportunities 26
Richter Gedeon Nyrt – Threats 27
Richter Gedeon Nyrt – Key Competitors 28
Section 3 – Company Financial Ratios 29
Financial Ratios – Capital Market Ratios 29
Financial Ratios – Annual Ratios 30
Performance Chart 33
Financial Performance 33
Financial Ratios – Interim Ratios 34
Financial Ratios – Ratio Charts 35
Section 4 – Company’s Lifesciences Financial Deals and Alliances 36
Richter Gedeon Nyrt, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 36
Richter Gedeon Nyrt, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 37
Richter Gedeon Nyrt, Recent Deals Summary 38
Section 5 – Appendix 39
Methodology 39
Ratio Definitions 39
About GlobalData 43
Contact Us 43
Disclaimer 43

List of Tables
Richter Gedeon Nyrt, Key Facts 6
Richter Gedeon Nyrt, Key Employees 7
Richter Gedeon Nyrt, Key Employee Biographies 8
Richter Gedeon Nyrt, Major Products and Services 9
Richter Gedeon Nyrt, History 11
Richter Gedeon Nyrt, Other Locations 16
Richter Gedeon Nyrt, Subsidiaries 16
Richter Gedeon Nyrt, Joint Venture 18
Richter Gedeon Nyrt, Key Competitors 28
Richter Gedeon Nyrt, Ratios based on current share price 29
Richter Gedeon Nyrt, Annual Ratios 30
Richter Gedeon Nyrt, Annual Ratios (Cont...1) 31
Richter Gedeon Nyrt, Annual Ratios (Cont...2) 32
Richter Gedeon Nyrt, Interim Ratios 34
Richter Gedeon Nyrt, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 36
Richter Gedeon Nyrt, Pharmaceuticals & Healthcare, Deals By Type, 2012 to YTD 2018 37
Richter Gedeon Nyrt, Recent Deals Summary 38
Currency Codes 39
Capital Market Ratios 39
Equity Ratios 40
Profitability Ratios 40
Cost Ratios 41
Liquidity Ratios 41
Leverage Ratios 42
Efficiency Ratios 42

List of Figures
Richter Gedeon Nyrt, Performance Chart (2013 - 2017) 33
Richter Gedeon Nyrt, Ratio Charts 35
Richter Gedeon Nyrt, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 36
Richter Gedeon Nyrt, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 37

★海外企業調査レポート[Richter Gedeon Nyrt (RICHTER):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Mayne Pharma Group Ltd (MYX):製薬・医療:M&Aディール及び事業提携情報
    Summary Mayne Pharma Group Ltd (Mayne Pharma), formerly HalcyGen Pharmaceuticals Ltd, a subsidiary of Mayne Pharma Group Ltd, is a specialty pharmaceutical company that manufactures and markets branded and generic medicinal products. The company’s products comprise erymax capsules, kapanol capsules, …
  • Wilmar International Ltd (F34):企業の財務・戦略的SWOT分析
    Wilmar International Ltd (F34) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Ameriprise Financial, Inc. (AMP):企業の財務・戦略的SWOT分析
    Ameriprise Financial, Inc. (AMP) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • Ringkjoebing Landbobank A/S:企業の戦略・SWOT・財務情報
    Ringkjoebing Landbobank A/S - Strategy, SWOT and Corporate Finance Report Summary Ringkjoebing Landbobank A/S - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Zhejiang Jolly Pharmaceutical Co Ltd (300181):製薬・医療:M&Aディール及び事業提携情報
    Summary Zhejiang Jolly Pharmaceutical Co Ltd (Zhejiang Jolly Pharma) is a producer and marketer of pharmaceutical products. The company offers products in the form of tablets, capsules, granules, injections, dry powders, and others. Its products include Wuling powder, pseudomonas moth powder, cordyc …
  • Edan Instruments Inc (300206):製品パイプライン分析
    Summary Edan Instruments Inc (Edan Instruments) is a medical equipment provider that offers ECG equipments. The company offers diagnostic ECG, patient monitoring devices, obstetrics and gynaecology monitoring systems, ultrasound imaging, point-of-care testing, in-vitro diagnostics and veterinary equ …
  • Ezion Holdings Limited:企業のM&A・事業提携・投資動向
    Ezion Holdings Limited - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Ezion Holdings Limited Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions …
  • Unilever Pakistan Limited:企業の戦略・SWOT・財務分析
    Unilever Pakistan Limited - Strategy, SWOT and Corporate Finance Report Summary Unilever Pakistan Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Ferring International Center SA:企業の戦略的SWOT分析
    Ferring International Center SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • UDG Healthcare Plc (UDG):製薬・医療:M&Aディール及び事業提携情報
    Summary UDG Healthcare plc (UDG) formerly, United Drug plc is a provider of outsourced commercial solutions to healthcare companies. It offers supply chain, packaging, sales and marketing, medical and regulatory services to healthcare manufacturers and pharmaceutical retailers. Its major activities …
  • NEC Capital Solutions Ltd. (8793):企業の財務・戦略的SWOT分析
    NEC Capital Solutions Ltd. (8793) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Vital Images Inc:企業の戦略的SWOT分析
    Vital Images Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Vattenfall AB.:企業の戦略・SWOT・財務分析
    Vattenfall AB. - Strategy, SWOT and Corporate Finance Report Summary Vattenfall AB. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • Principia Biopharma Inc (PRNB):製薬・医療:M&Aディール及び事業提携情報
    Summary Principia Biopharma Inc (Principia Biopharma) is a clinical stage biopharmaceutical company that designs and develops oral small molecule drug therapies for immune disorders and cancer. The company, through its proprietary Tailored Covalency platform, develops a portfolio of drug candidates …
  • Avista Corporation
    Avista Corporation - Strategy, SWOT and Corporate Finance Report Summary Avista Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and …
  • Pentair Plc (PNR):石油・ガス:M&Aディール及び事業提携情報
    Summary Pentair Plc (Pentair) is an industrial manufacturing company. It designs, manufactures and markets water treatment systems and high-performance products and solutions for filtration, separation and fluid process management. Its product portfolio includes point-of-entry and point-of-use filtr …
  • American Bio Medica Corp (ABMC):企業の財務・戦略的SWOT分析
    Summary American Bio Medica Corp (ABMC) is a biotechnology company that develops, manufactures and markets immunoassay test kits. The company’s products include Rapid TOX, a point of collection testing product that detects 1-10 drugs of abuse in a urine specimen; Rapid One, a test cassette which is …
  • Lakeview Hotel Investment Corp.:企業の戦略・SWOT・財務情報
    Lakeview Hotel Investment Corp. - Strategy, SWOT and Corporate Finance Report Summary Lakeview Hotel Investment Corp. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Rolta India Ltd (ROLTA):企業の財務・戦略的SWOT分析
    Rolta India Ltd (ROLTA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Fluxion Biosciences Inc:医療機器:M&Aディール及び事業提携情報
    Summary Fluxion Biosciences Inc (Fluxion) is a provider of analytical instruments for functional cellular analyses. The company’s liquid biopsy technologies include IsoFlux CTC liquid biopsy system, ERASE-Seq variant caller for liquid biopsies and the Spotlight 59 for ultra-sensitive NGS mutation de …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆